Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Description:**\n7,8-Diamino-nonanoic acid is an amino fatty acid with amino substituents at positions 7 and 8. It is a naturally occurring intermediate in the biosynthetic pathway of biotin in plants and microorganisms. Its chemical structure and the enzymes involved in its synthesis are targets for the development of herbicides and antimicrobial drugs[1][3][5].\n\n**Mechanism of Action:**\nAs an intermediate in biotin biosynthesis (specifically as a precursor to dethiobiotin), it does not have a direct pharmacological mechanism but is essential for microbial growth. Inhibition of its synthesis or metabolism can disrupt biotin production in target organisms[1][3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on 7,8-diaminononanoic acid.